GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioPharma Credit BPCR.L · GBp

Financials · LSE · 🇬🇧 United Kingdom

Compare

0.99p

-0.20%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

$129.9m

FY2017FY2025

Total assets

$1.17bn

FY2017FY2025

Shareholders' equity

$1.15bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating income$129.8m$122.2m$108.5m$182.3m$85.0m$89.1m$122.3m$70.1m$27.1m
Net income$129.9m$122.2m$108.5m$182.3m$85.0m$89.1m$122.3m$70.1m$27.2m
Diluted earnings per share0.120.100.080.130.060.060.090.070.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$1.17bn$1.20bn$1.36bn$1.36bn$1.37bn$1.39bn$1.43bn$1.39bn$925.5m
Cash and short-term investments$12.6m$5.6m$135.1m$120.5m$94.7m$193.3m$296.6m$363.6m$350.8m
Total liabilities$17.6m$17.9m$15.9m$26.3m$6.9m$9.4m$25.2m$13.3m$2.9m
Shareholders' equity$1.15bn$1.18bn$1.34bn$1.34bn$1.36bn$1.38bn$1.40bn$1.38bn$922.6m
Shares outstanding1,129m1,222m1,303m1,374m1,374m1,374m1,374m1,064m761m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Operating income$50.4m$57.1m$72.6m$50.3m$71.9m$36.0m$37.5m$18.8m
Net income$50.4m$57.1m$72.8m$50.3m$71.8m$35.9m$37.5m$18.8m
Diluted earnings per share0.040.050.060.040.060.030.030.01
Total assets$1.14bn$1.17bn$1.16bn$1.20bn$1.23bn$1.23bn$1.36bn$1.36bn
Cash and short-term investments$68.7m$12.6m$4.3m$5.6m$37.1m$37.1m$135.1m$135.1m
Shareholders' equity$1.14bn$1.15bn$1.15bn$1.18bn$1.23bn$1.23bn$1.34bn$1.34bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.7%8.9%—
Operating income-10.7%7.8%—
Net income-10.7%7.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.08.810.17.215.715.311.516.129.3
Price to sales7.48.76.87.115.115.011.314.423.7

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 8 Oct 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.070.070.070.0860.070.070.070.07

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.